Skip to content

CardioInsight 1 RBBB

Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05555966
Acronym
CardioInsight1
Enrollment
93
Registered
2022-09-27
Start date
2017-09-01
Completion date
2024-12-31
Last updated
2022-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

Cardiac resynchronization therapy (CRT) is an established therapy for symptomatic heart failure patients. However, there are still 30 to 40% of studied patients being nonresponder to CRT. The plausible reasons of lack of effect of CRT in these patients include relative less baseline electrical dyssynchrony. The aim of our study is to investigate whether there is an optimal configuration of CRT delivery that varies between patients with different pattern of activation delay.

Interventions

To study the feasibility to optimize configuration of CRT delivery for acute correction of electrical dyssynchrony using a noninvasive mapping of global electrical activation

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (aged 18 or above) of both sexes * Ischemic or non-ischemic cause of heart failure * QRS duration \> 120 ms, non-left bundle branch block (LBBB) type of conduction disturbance * NYHA class III or above * Informed consent by the patient * Already received stable dose of guideline directed medical therapy for at least 3 months

Exclusion criteria

* LBBB patients * Pregnant women * Participation in another study * Patient with contraindication to left ventricle catheterization by a retrograde aortic approach

Design outcomes

Primary

MeasureTime frameDescription
Left Ventricle (LV) end systolic volume reduction6 monthsThe responder rate of greater than 10% of LV end systolic volume reduction measured by echocardiogram

Secondary

MeasureTime frameDescription
Hemodynamic response monitoringDuring proceduremonitor the difference in hemodynamic responses of different methods of CRT delivery method. The hemodynamic response will be maximal dp/dt as measured by pressure wire introduced into the left ventricle during the procedure.
Procedure outcome with optimal CRT deliveryDuring procedureProcedure outcome measured by procedure duration and implantation success rate of the optimal CRT delivery method as determined by the best improvement in electrical dyssynchrony indices.
Cine images and chest X ray6 monthsCine images (PA, LAO 300, RAO 300) and Chest X ray (PA view) of patients will be obtained for evaluation of changes in disease
Echocardiogram parameter: left ventricular systolic and diastolic volume6 monthsleft ventricular systolic and diastolic volume at baseline, 3 months and 6 months : , left ventricular ejection fraction, degree of mitral regurgitation, strain imaging will be aggregated to arrive at an overall change in echocardiogram parameters as together they represent integrated heart function collectively, as reflected by the listed echocardiogram parameters.
Multi-dimensional Quality of life changes6 monthschange in New York Heart Association (NYHA) class, 6 minute hall walk test, HF Patient Global Assessment Questionnaire and quality of life using Minnesota's living with heart failure (MLWHF) questionnaire at baseline, 3 months and 6 months.
Device set-up parameter :defibrillation threshold6 monthsDevice parameters including defibrillation threshold at implant and 6 months follow-up.
Post-operation Complication rate6 monthsPeri-operative and 6 months follow-up complications rate: 1. Thromboembolic event 2. Dislodgement and migration of pacing leads 3. Phrenic nerve stimulation 4. Others
Device set-up parameter :defibrillation sensitivity6 monthsDevice set-up parameter :defibrillation sensitivity at implant and 6 months follow-up
Electrical dyssynchrony indexDuring procedureThe acute electrical dyssynchrony indices (the standard deviation of activation times throughout the epicardium) of different methods of CRT delivery. Lower indicate larger improvement.
Change in 6 minute hall walk test6 monthsChange in 6 minute hall walk test result, at baseline, 3 months and 6 months.
Change in HF Patient Global Assessment Questionnaire6 monthsHF Patient Global Assessment Questionnaire at baseline, 3 months and 6 months.
Change in quality of life6 monthsChange in quality of life assessed by Minnesota's living with heart failure (MLWHF) questionnaire at baseline, 3 months and 6 months.
Implantation success rate with optimal CRT deliveryDuring procedureImplantation success rate of the optimal CRT delivery method as determined by the best improvement in electrical dyssynchrony indices.
Echocardiogram parameter: left ventricular ejection fraction6 monthsEchocardiogram parameter: left ventricular ejection fraction at baseline, 3 months and 6 months
Echocardiogram parameter: degree of mitral regurgitation6 monthsEchocardiogram parameter: degree of mitral regurgitation at baseline, 3 months and 6 months
Echocardiogram parameter: strain imaging6 monthsEchocardiogram parameter: strain imaging at baseline, 3 months and 6 months
Device set-up parameter: lead impedance of pacing leads6 monthsDevice set-up parameter: lead impedance of pacing leads at implant and 6 months follow-up

Countries

Hong Kong

Contacts

Primary ContactDaniel Xu
danielxu@cuhk.edu.hk35051518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026